|
Volumn 7, Issue 5, 2004, Pages 435-438
|
Antimicrobials: The challenge of antibiotic resistant bacterial pathogens: The medical need, the market and prospects for new antimicrobial agents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BACTERIAL PROTEIN;
BETA LACTAM;
DIHYDROFOLATE REDUCTASE INHIBITOR;
MACROLIDE;
N (5 FLUORO 1 OXIDO 2 PYRIDINYL) 1 [2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANOYL]PROLINAMIDE;
OXAZOLIDINONE DERIVATIVE;
PENICILLIN G;
PROTEIN INHIBITOR;
PROTEOME;
QUINOLONE;
TETRACYCLINE;
UNCLASSIFIED DRUG;
VANCOMYCIN;
ACINETOBACTER BAUMANNII;
ANTIBIOTIC RESISTANCE;
BACTERIAL COLONIZATION;
BACTERIAL GENE;
BACTERIAL GROWTH;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
BACTERIAL VIRULENCE;
BACTERIUM ISOLATE;
CELL ANCHORAGE;
CYTOLYSIS;
DRUG EFFICACY;
DRUG TOLERANCE;
EDITORIAL;
GENE EXPRESSION;
GENOMICS;
GRAM POSITIVE BACTERIUM;
GROWTH RATE;
HOSPITAL INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
MEDICAL RESEARCH;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MULTIDRUG RESISTANCE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PATHOGENESIS;
PREDICTION;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
TRANSPOSON;
BACTERIUM;
DRUG EFFECT;
GENETICS;
HUMAN;
MICROBIOLOGY;
ACINETOBACTER;
ACINETOBACTER BAUMANNII;
BACTERIA (MICROORGANISMS);
HUMAN IMMUNODEFICIENCY VIRUS;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MYCOBACTERIUM;
MYCOBACTERIUM TUBERCULOSIS;
POSIBACTERIA;
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS;
STREPTOCOCCUS PNEUMONIAE;
TRANSPOSONS;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
HUMANS;
|
EID: 4644226625
PISSN: 13695274
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mib.2004.08.017 Document Type: Editorial |
Times cited : (44)
|
References (4)
|